Notably, our study is the first to demonstrate that CAPE significantly upregulates renal GPX4 and SLC7A11 expression while downregulating TFR1 and reducing iron overload in DKD mice compared to non-diabetic controls. Here, GPX4 is linked to diabetic kidney disease.